Skip to main content
Caplight Logo









Stratagen Bio

Stratagen Bio

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://stratagenbio.com/

Last Round

Seed

Oct 18, 2024

Total Funding Raised

$475,000

Company Overview

Stratagen Bio is a medical devices and equipment company that develops oxygen-sensing technology to incorporate direct and absolute measurements of tissue oxygen in the treatment planning process for applications in cancer, trauma, ischemic injuries, and vascular disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

implantable sensortissue oxygen monitoringMRI-compatible sensorbiomarker assessmentmedical deviceoncology diagnosticsquantitative imagingradiation therapy planningmagnetic resonance imagingMRIsmart implantmedtechdigital biomarker

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stratagen Bio Comparables

Compare Stratagen Bio with similar companies based on industry and business-model similarity.

Stratagen Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Clin-EPR, LLC
71%
Profusa, Inc.
65%
Oxford Optronix
64%

Stratagen Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 18, 2024
GrantMay 1, 2024
GrantSep 14, 2023

Stratagen Bio Investors

Notable investors and investment history

Stratagen Bio investors
InvestorRounds
National Cancer InstituteGrant
Bertarelli FoundationGrant
Everywhere VenturesSeed, Pre Seed
Impact FirstSeed
January VenturesSeed
Alumni VenturesSeed, Pre Seed
Looking Glass CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 116% MoM.

  • Apr 15, 2026

    Monthly visitors increased 268% MoM.

Stratagen Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Stratagen Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Stratagen Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range5
Year Founded2019
Last FundingOct 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?